UPDATE: Emergent BioSolutions says FDA has accepted its Anthrax vaccine candidate for review https://finviz.com/quote.ashx?t=EBS $32.34 https://www.marketwatch.com/story/emergent-biosolutions-says-fda-has-accepted-its-anthrax-vaccine-candidate-for-review-2022-06-24?siteid=rss